From Book News, Inc.
New edition of a text that includes current data regarding the progress that has been made in treating leukemia patients in terms of diagnostic techniques, therapeutic measures, and prognosis. The 30 contributions cover the history and biology of leukemia; myelopoiesis and lymphopoiesis; molecular cytogenetics, immunobiology, and epidemiology; causes such as radiation, chemicals, and viruses; diagnosis, classification and assessment of response to treatment; detection of minimal residual disease; management of the disease and complications; pharmacology; transplantation; and various types of leukemia. Illustrated with b&w and color images and charts. Edited by Henderson (emeritus medicine, State U. of New York), T. Andrew Lister (clinical oncology, St. Bartholomew's Hospital) and Mel F. Greaves (cell biology, Institute of Cancer Research).Copyright © 2004 Book News, Inc., Portland, OR


Book Description
An international roster of field-leading experts delivers the seventh edition of the definitive textbook, LEUKEMIA. This classic provides comprehensive guidance on all aspects of leukemia, from etiology and biology to clinical features and therapy. This edition now also provides the molecular basis of several leukemias. It reflects the most exciting period of research in the field in a quarter century, and features information on molecular biology and molecular genetics, as well as biological therapy.


Book Info
State Univ. of New York, Buffalo. Major, clinical reference covers the history, biology, diagnosis, and treatment options for this disease. Color plates and extensive references are included. Previous edition: c1996. DNLM: Leukemia.


About the Author
Edward S. Henderson, MD, State University at Buffalo, Buffalo, NY; T. Andrew Lister, MD, Medical Oncology Unit, St. Bartholomew's Hospital, London, UK; and Mel F. Greaves, Director, Leukemia Research Fund Centre, Institute of Cancer Research, London, UK

ANNOTATION

The book contains both black-and-white and color illustrations.

FROM THE PUBLISHER

Henderson, Edward S., MD(Food and Drug Administration); Lister, T. Andrew, MD(St Bartholomew's Hospital, London); Graves, Mel F., PhD(Institute of Cancer Research)

The contributors represent the specialties of hematology, oncology, clinical chemistry, cancer research, epidemiology, genetics, internal medicine, and pediatrics. Most are from U.S. academic medical centers, with others from institutions in Japan, Germany, Scotland, the Netherlands, England, France, Italy, and Canada. Institutions prominently represented include Univ of Minnesota, St. Bartholomew's Hospital - London, Kumamoto Univ, and the National Cancer Institute.

SYNOPSIS

New edition of a text that includes current data regarding the progress that has been made in treating leukemia patients in terms of diagnostic techniques, therapeutic measures, and prognosis. The 30 contributions cover the history and biology of leukemia; myelopoiesis and lymphopoiesis; molecular cytogenetics, immunobiology, and epidemiology; causes such as radiation, chemicals, and viruses; diagnosis, classification and assessment of response to treatment; detection of minimal residual disease; management of the disease and complications; pharmacology; transplantation; and various types of leukemia. Illustrated with b&w and color images and charts. Edited by Henderson (emeritus medicine, State U. of New York), T. Andrew Lister (clinical oncology, St. Bartholomew's Hospital) and Mel F. Greaves (cell biology, Institute of Cancer Research). Annotation c. Book News, Inc., Portland, OR

FROM THE CRITICS

Martin S. Tallman

This is the sixth edition of what has become a well-recognized text in leukemia. It is comprehensive in its attempt to cover the etiology, pathogenesis, clinical features, management, and complications of all types of acute and chronic leukemias. The authors intend to keep abreast of the many rapid changes in the molecular basis of acute leukemia, advances in treatment strategies, cytogenetics, immunophenotyping,and therapeutic strategies, including the role of hematopoietic growth factors and all-trans retinoic acid in acute promyelocytic leukemia. The goals of the authors are well justified; indeed, they meet their objectives fully. This book is written for a broad audience, including students, house officers, and hematologists/oncologists, but it will be very informative for the nonhematologist physician as well. The authors have solicited chapters from leading authorities in their fields, and the text is edited so that there is a logical sequence of topics. The chapters are written in a way that is easy to understand. All chapters have an extensive number of references. There are numerous illustrations that satisfactorily enhance the text. The table of contents and index are similarly easy to use. There are numerous well-reproduced color photomicrographs that add to the overall appearance of the text. The chapter on biologic therapy of leukemia is particularly timely and thorough. This sixth edition will be a useful addition for any institutional or personal library. The authors have succeeded in addressing the many new advances in the field, including our improved ability to use cytogenetics, immunophenotyping, and molecular genetics to understand, classify, and treat thevarious leukemias. The easy readability will make this book particularly useful for house officers and fellows.

Doody Review Services

Reviewer: Martin S. Tallman, MD (Northwestern University Medical School)Description: This is the sixth edition of what has become a well-recognized text in leukemia. It is comprehensive in its attempt to cover the etiology, pathogenesis, clinical features, management, and complications of all types of acute and chronic leukemias. Purpose: The authors intend to keep abreast of the many rapid changes in the molecular basis of acute leukemia, advances in treatment strategies, cytogenetics, immunophenotyping,and therapeutic strategies, including the role of hematopoietic growth factors and all-trans retinoic acid in acute promyelocytic leukemia. The goals of the authors are well justified; indeed, they meet their objectives fully. Audience: This book is written for a broad audience, including students, house officers, and hematologists/oncologists, but it will be very informative for the nonhematologist physician as well. Features: The authors have solicited chapters from leading authorities in their fields, and the text is edited so that there is a logical sequence of topics. The chapters are written in a way that is easy to understand. All chapters have an extensive number of references. There are numerous illustrations that satisfactorily enhance the text. The table of contents and index are similarly easy to use. There are numerous well-reproduced color photomicrographs that add to the overall appearance of the text. The chapter on biologic therapy of leukemia is particularly timely and thorough. Assessment: This sixth edition will be a useful addition for any institutional or personal library. The authors have succeeded in addressing the many new advances in the field, including our improved ability to use cytogenetics, immunophenotyping, and molecular genetics to understand, classify, and treat the various leukemias. The easy readability will make this book particularly useful for house officers and fellows.

RATING

3 Stars from Doody

ACCREDITATION

Henderson, Edward S., MD (Food and Drug Administration); Lister, T. Andrew, MD (St Bartholomew's Hospital, London); Graves, Mel F., PhD (Institute of Cancer Research)